We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more call options, than puts

Call options by funds: $36M | Put options by funds: $30.1M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.63%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$30.1M
Net Calls
+$5.98M
Net Calls Change
+$5.98M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.